Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 8
Submit an article Journal homepage
331
Views
18
CrossRef citations to date
0
Altmetric
Review

PPAR-γ signaling pathway in placental development and function: A potential therapeutic target in the treatment of gestational diseases

Costas Giaginis University of Athens, Department of Forensic Medicine and Toxicology, Medical School, 75, M. Asias street, Goudi, Athens, GR11527, Greece +30 210 7462413; +30 210 7716098; [email protected]
,
Evangelia Spanopoulou University of Athens, Department of Forensic Medicine and Toxicology, Medical School, 75, M. Asias street, Goudi, Athens, GR11527, Greece +30 210 7462413; +30 210 7716098; [email protected]
&
Stamatios Theocharis University of Athens, Department of Forensic Medicine and Toxicology, Medical School, 75, M. Asias street, Goudi, Athens, GR11527, Greece +30 210 7462413; +30 210 7716098; [email protected]
, MD PhD
Pages 1049-1063 | Published online: 12 Jul 2008

Bibliography

  • Schaiff WT, Barak Y, Sadovsky Y. The pleiotropic function of PPARγ in the placenta. Mol Cell Endocrinol 2006;249:10-5
  • Froment P, Gizard F, Defever D, et al. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol 2006;189:199-209
  • Cross JC, Anson-Cartwright L, Scott IC. Transcription factors underlying the development and endocrine functions of the placenta. Recent Prog Horm Res 2002;57:221-34
  • Burton GJ, Jauniaux E, Charnock-Jones DS. Human early placental development: potential roles of the endometrial glands. Placenta 2007;28:S64-9
  • Nadra K, Anghel SI, Joye E, et al. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β/δ. Mol Cell Biol 2006;26:3266-81
  • Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000;92:35-43
  • Tarrade A, Schoonjans K, Guibourdenche J, et al. PPARγ/RXRα heterodimers are involved in human CGβ synthesis and human trophoblast differentiation. Endocrinology 2001;142:4504-14
  • Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-88
  • Berger J, Moller DE. The mechanisms of action of PPARs. Ann Rev Med 2002;53:409-35
  • Nolte RT, Wisely GB, Westin S, et al. Ligand binding and co-activator assembly of the peroxisome proliferators activated receptor-γ. Nature 1998;395:137-43
  • Gearing KL, Gottlicher M, Teboul M, et al. Interaction of the peroxisome proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci USA 1993;90:1440-4
  • Feige JN, Gelman L, Michalik L, et al. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progr Lipid Res 2006;45:120-59
  • Feinstein DL, Spangolo A, Akar C, et al. Receptor-independent actions of PPAR thiazolidinedione agonists: is a mitochondrial function the key? Biochem Pharm 2005;70:177-88
  • Tolon RM, Castillo AI, Aranda A. Activation of the prolactin protein gene by peroxisome proliferator-activated receptor-α appears to be DNA binding-independent. J Biol Chem 1998;273:26652-61
  • Wilson TM, Brown PJ, Strenbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Chem 2000;43:527-50
  • Schopfer FJ, Lin Y, Baker PR, et al. Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand. Proc Natl Acad Sci USA 2005;102:2340-5
  • Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic Thiazolidinedione is a high affinity ligand for peroxisome-proliferator-activated receptor γ (PPARγ). J Biol Chem 1995;270:12953-6
  • Theocharis S, Margeli A, Kouraklis G. Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents. Curr Med Chem Anticancer Agents 2003;3:239-51
  • Theocharis S, Margeli A, Vielh P, Kouraklis G. Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators. Cancer Treat Rev 2004;30:545-54
  • Giaginis C, Margeli A, Theocharis S. Peroxisome proliferator activated receptor-γ ligands as investigational modulators of angiogenesis. Expert Opin Investig Drugs 2007;16:1561-72
  • Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Peroxisome proliferator activated receptor-γ ligands as bone turnover modulators. Expert Opin Investig Drugs 2007;16:195-207
  • Hamerman D. Osteoporosis and atheroslerosis: biological linkages and the emergence of dual-purpose therapies. Q J Med 2005;98:467-84
  • Tenenbaum A, Motro M, Fisman EZ. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol 2005;4:14. Published online 16 September 2005, doi:10.1186/1475-2840-4-14
  • Michalik L, Desvergne B, Dreyer C, et al. PPAR expression and function during vertebrate development. Int J Dev Biol 2002;46:105-14
  • Wang Q, Fujii H, Knipp GT. Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 2002;23:661-71
  • Barak Y, Nelson MC, Ong ES, et al. PPARγ is required for placental, cardiac, and adipose tissue development. Mol Cell 1999;4:585-95
  • Barak Y, Liao D, He W, et al. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 2002;99:303-8
  • Kubota N, Terauchi Y, Miki H, et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597-609
  • Asami-Miyagishi R, Iseki S, Usui M, et al. Expression and function of PPARγ in rat placental development. Biochem Biophys Res Commun 2004;315:497-501
  • Schaiff WT, Knapp FF JR, Barak Y, et al. Ligand-activated peroxisome proliferator activated receptor γ alters placental morphology and placental fatty acid uptake in mice. Endocrinology 2007;148:3625-34
  • Xu Y, Cook TJ, Knipp GT. Effects of di-(2-ethylhexyl)-phthalate (DEHP) and its metabolites on fatty acid homeostasis regulating proteins in rat placental HRP-1 trophoblast cells. Toxicol Sci 2005;84:287-300
  • Shalom-Barak T, Nicholas JM, Wang Y, et al. Peroxisome proliferator-activated receptor γ controls Muc1 transcription in trophoblasts. Mol Cell Biol 2004;24:10661-9
  • Hewitt DP, Mark PJ, Waddell BJ. Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and the effect of increased glucocorticoid exposure. Biol Reprod 2006;74:23-8
  • Miles JR, Farin CE, Rodriguez KF, et al. Effects of embryo culture on angiogenesis and morphometry of bovine placentas during early gestation. Biol Reprod 2005;73:663-71
  • Langdown ML, Sugden MC. Enhanced placental GLUT1 and GLUT3 expression in dexamethasone-induced fetal growth retardation. Mol Cell Endocrinol 2001;185:109-17
  • Crawford SE, Qi C, Misra P, et al. Defects of the heart, eye and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors. J Biol Chem 2002;277:3585-92
  • Antonson P, Schuster GU, Wang L, et al. Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol Cell Biol 2003;23:1260-8
  • Zhu Y-J, Crawford SE, Stellmach V, et al. Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J Biol Chem 2003;278:1986-90
  • Fournier T, Handschuh K, Tsatsaris V, Evain-Brion D. Involvement of PPARγ in human trophoblast invasion. Placenta Trophoblast Res 2007;21:S76-81
  • Fournier T, Tsatsaris V, Handschuh K, Evain-Brion D. PPARs and the placenta. Placenta 2007;28:65-76
  • Schaiff WT, Carlson MG, Smith SD, et al. Peroxisome proliferator-activated receptor-γ modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab 2000;85:3874-81
  • Wang LH, Yang XY, Zhang X, et al. Transcriptional inactivation of STAT3 by PPARγ suppresses IL-6-responsive multiple myeloma cells. Immunity 2004;20:205-18
  • Waite LL, Person EC, Zhou Y, et al. Placental peroxisome proliferator-activated receptor-γ is up-regulated by pregnancy serum. J Clin Endocrinol Metab 2000;85:3808-14
  • Capparuccia L, Marzioni D, Giordano A, et al. PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma. Mol Hum Reprod 2002;8:574-9
  • Tarrade A, Schoonjans K, Pavan L, et al. PPARγ/RXRα heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 2001;86:5017-24
  • Marvin KW, Eykholt RL, Keelan JA, et al. The 15-deoxy-Δ12,14-prostaglandin J2 receptor, peroxisome proliferator activated receptor-γ (PPARγ) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta 2000;21:436-40
  • Fournier T, Pavan L, Tarrade A, et al. The role of PPAR-γ/RXR-α heterodimers in the regulation of human trophoblast invasion. Ann NY Acad Sci 2002;973:26-30
  • Pavan L, Tarrade A, Hermouet A, et al. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARγ in cell invasion process. Carcinogenesis 2003;24:1325-36
  • Schaiff WT, Bildirici I, Cheong M, et al. Peroxisome proliferator-activated receptior-γ and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab 2005;90:4267-75
  • Schild RL, Sonnenberg-Hirche CM, Schaiff WTB, et al. The kinase p38 regulates peroxisome proliferator activated receptor-γ in human trophoblasts. Placenta 2006;27:191-9
  • Dunn-Albanese LR, Ackerman WE 4TH, Xie Y, et al. Reciprocal expression of peroxisome proliferator-activated receptor γ and cyclooxygenase-2 in human term parturition. Am J Obstet Gynecol 2004;190:809-16
  • Daoud G, Simoneau L, Masse A, et al. Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation. Biochim Biophys Acta 2005;1687:181-94
  • Schild RL, Schaiff WT, Carlson MG, et al. The activity of PPARγ in primary human trophoblasts is enhanced by oxidized lipids. J Clin Endocrinol Metab 2002;87:1105-10
  • Handschuh K, Guibourdenche J, Tsatsaris V, et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. Endocrinology 2007;148:5011-9
  • Lappas M, Rice GE. Phospholipase A2 isozymes in pregnancy and parturition. Prostaglandins Leukot Essent Fatty Acids 2004;70:87-100
  • Lappas M, Permezel M, Georgiou HM, Rice GE. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-γ: effect of 15-deoxy-Δ(12,14)-PGJ(2) and troglitazone. J Clin Endocrinol Metab 2002;87:4667-72
  • Xu Y, Wang Q, Cook TJ, Knipp GT. Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes. J Pharm Sci 2007;96:2582-606
  • Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2. Endocrinology 2005;146:3334-42
  • Lappas M, Permezel M, Rice GE. 15-Deoxy-δ(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta 2006;27:1060-72
  • Lappas M, Permezel M, Holdsworth SJ, et al. Antiinflammatory effects of the cyclopentenone isoprostane 15-A(2)-IsoP in human gestational tissues. Free Radic Biol Med 2007;42:1791-6
  • Berry EB, Eykholt R, Helliwell RJ, et al. Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term. Mol Pharmacol 2003;64:1586-90
  • Handschuh K, Guibourdenche J, Guesnon M, et al. Modulation of PAPP-A expression by PPARγ in human first trimester trophoblast. Placenta 2006;27:S127-34
  • Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007;50:938-48
  • Barnes-Powell LL. Infants of diabetic mothers: the effects of hyperglycemia on the fetus and neonate. Neonatal Netw 2007;26:283-90
  • Jawerbaum A, Capobianco E, Pustovrh C, et al. Influence of peroxisome proliferator-activated receptor γ activation by its endogenous ligand 15-deoxy δ12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol Hum Reprod 2004;10:671-6
  • Meirhaeghe A, Amouyel P. Impact of genetic variation of PPARγ in humans. Mol Genet Metabol 2004;83:93-102
  • Meirhaeghe A, Boreham CA, Murray LJ, et al. A possible role for the PPARG Pro12Ala polymorphism in preterm birth. Diabetes 2007;56:494-8
  • Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPAR2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998;20:159-61
  • Suwaki N, Masuyama H, Masumoto A, et al. Expression and potential role of peroxisome proliferator-activated receptor γ in the placenta of diabetic pregnancy. Placenta 2007;28:315-23
  • Capobianco E, Jawerbaum A, Romanini MC, et al. 15-Deoxy-Δ12,14-prostaglandin J2 and peroxisome proliferator-activated receptor γ (PPARγ) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARγ agonist on nitridergic and lipid placental metabolism. Reprod Fertil Dev 2005;17:423-33
  • Holmes HJ, Casey BM, Bawdon RE. Placental transfer of rosiglitazone in the ex vivo human perfusion model. Am J Obstet Gynecol 2006;195:1715-9
  • Chan LY, Yeung JH, Lau TK. Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril 2005;83:955-8
  • Yaris F, Yaris E, Kadioglu M, et al. Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reprod Toxicol 2004;18:619-21
  • Kalyoncu NI, Yaris F, Ulku C, et al. A case of rosiglitazone exposure in the second trimester of pregnancy. Reprod Toxicol 2005;19:563-4
  • Cho H, Tai HH. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents. Prostaglandins Leukot Essent Fatty Acids 2002;67:461-5
  • Rodie VA, Young A, Jordan F, et al. Human placental peroxisome proliferator-activated receptor δ and γ expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig 2005;12:320-9
  • Waite LL, Louie RE, Taylor RN. Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 2005;90:620-6
  • Toth B, Hornung D, Scholz C, et al. Peroxisome proliferator-activated receptors: New players in the field of reproduction. Am J Reprod Immunol 2007;58:289-310
  • Giordano FJ, Johnson RS. Angiogenesis: the role of the microenvironment in flipping the switch. Curr Opin Genet Dev 2001;11:35-40
  • Hickey MM, Simon MC. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 2006;76:217-57
  • Liao D, Johnson RS. Hypoxia: a ket regulator of angiogenesis in cancer. Cancer Met Rev 2007;26:281-90
  • Jensen RL, Ragel BT, Whang K, Gillespie D. Inhibition of hypoxia inducible factor-1α (HIF-1-α) decrease vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol 2006;78:233-47
  • Morris JM, Gopaul NK, Endresen MJ, et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1998;105:1195-9
  • Li R, Chase M, Jung SK, et al. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 2005;289:E591-9
  • Rosario GX, Konno T, Soares MJ. Maternal hypoxia activates endovascular trophoblast cell invasion. Dev Biol 2008;314:362-75
  • Alsat E, Wyplosz P, Malassine A, et al. Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro. J Cell Physiol 1996;168:346-53
  • Jiang B, Kamat A, Mendelson CR. Hypoxia prevents induction of aromatase expression in human trophoblast cells in culture: potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous protein-2). Mol Endocrinol 2000;14:1661-73
  • Jiang B, Mendelson CR. USF1 and USF2 mediate inhibition of human trophoblast differentiation and CYP19 gene expression by Mash-2 and hypoxia. Mol Cell Biol 2003;23:6117-28
  • Nisbet RE, Sutliff RL, Hartl CM. The role of peroxisome proliferator-activated receptors in pulmonary vascular diseases. PPAR Res 2007;2007:18797. Published online 30 April 2007, doi:10.1155/2007/18797
  • Crossno JT Jr, Garat CV, Reusch JE, et al. Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol 2007;292:L885-97
  • Diamond MP, Saed G. Modulation of the expression of peroxisome proliferators-activated receptors in human fibroblasts. Fertil Steril 2007;87:706-9
  • Li X, Kimura H, Hirota K, et al. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-γ in human proximal renal tubular cells. Nephrol Dial Transplant 2007;22:1041-51
  • Kim EH, Surh YJ. 15-deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 2006;72:1516-28
  • Lee KS, Kim SR, Park SJ, et al. Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1α in allergic airway disease of mice. J Allergy Clin Immunol 2006;118:120-7
  • Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human-placental development by oxygen tension. Science 1997;277:1669-72
  • Desmarais JA, Lopes FL, Zhang H, et al. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison). Biol Reprod 2007;77:829-39
  • Elchalal U, Humphrey RG, Smith SD, et al. Troglitazone attenuates hypoxia-induced injury in cultured term human trophoblasts. Am J Obstet Gynecol 2004;191:2154-9
  • Vähäkangas K, Myllynen P. Experimental methods to study human transplacental exposure to genotoxic agents. Mutat Res 2006;608:129-35
  • Myllynen P, Pasanen M, Pelkonen O. Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 2005;26:361-71
  • Myren M, Mose T, Mathiensen L, Knudsen LE. The human placenta-An alternative for studying foetal exposure. Toxicol In vitro 2007;21:1332-40
  • Feig DS, Briggs GG, Koren G. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift? Ann Pharmacother 2007;41:1174-80
  • Wieser F, Waite L, Depoix C, Taylor RN. PPAR action in human placental development and pregnancy and its complications. PPAR Res 2008;2008:527048
  • Martinez N, Capobianco E, White V, et al. PPARα activation regulates lipid metabolism in the feto-placental unit from diabetic rats. Reproduction 2008; In press. Published online 16 April 2008, doi:10.1530/REP-08-0028
  • Wang H, Xie H, Sun X, et al. Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor δ signaling is critical to pregnancy success. J Biol Chem 2007;282:37770-82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.